Over-the-Counter Birth-Control Pills Are Up for FDA Approval. Should You Switch?

If the FDA approves it, you could pick up your birth-control pills without visiting your doctor, the same way you buy Tylenol or Advil

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

For women weighing their contraception options, there are several things to considerShortly after the Supreme Court overturned Roe v. Wade, an application for an over-the-counter birth control pill was submitted to the FDA. WSJ’s Daniela Hernandez explains the difference between this pill and other contraceptives, and how over-the-counter access could affect reproductive care across the U.S.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJhealth /  🏆 413. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

ABC Considering WandaVision, Mandalorian to Counter Writers' Strike?ABC Entertainment Exec Ari Goldman on if the network would look to DisneyPlus programming like MarvelStudios' WandaVision & Loki and Lucasfilm's TheMandalorian to counter the writersstrike. / WGA AMPTP
Read more »

'The Uncanny Counter 2: Counter Punch' & 'Arthdal Chronicles 2: Sword of Aramun' returning back to back in the same time slot | allkpopAccording to media outlet reports on May 23 KST, tvN has determined its on-air schedule for the Sat-Sun evening drama time slot from now until Septem…
Read more »

FDA Approves Autoinjector Pen for Humira Biosimilar, CyltezoThe FDA approved a new autoinjection option for adalimumab-adbm, a biosimilar to AbbVie's adalimumab, ahead of Cyltezo's commercial launch on July 1, 2023.
Read more »

FDA Approves First Pill to Treat Moderate-to-Severe Crohn's DiseaseRinvoq is meant to treat adults with moderately to severely active Crohn's disease who have not had success with TNF (tumor necrosis factor) blockers. The daily pill is the first oral treatment for this group of patients.
Read more »